TY - JOUR
T1 - Evaluation of a new real-time PCR assay kit for quantification of human immunodeficiency virus RNA in plasma
AU - Sudo, Koji
AU - Shima, Takako
AU - Kondo, Makiko
AU - Kato, Shingo
AU - Mitsunobu, Imai
PY - 2007/1
Y1 - 2007/1
N2 - We evaluated the use of COBAS TaqMan HIV-1 for highly pure system (COBAS TaqMan) recently developed as a second-generation quantification of human immunodeficiency virus type 1 (HIV-1) RNA. The linearity, sensitivity, reproducibility, and effects of possibly interfering materials were examined and results compared to those of AMPLICOR HIV-1 MONITOR Test version 1.5 (AMPLICOR) using 6 virus isolates that were all different subtypes. Excellent linearity was obtained at 1.67 x 10(2)-1.73 x 10(6) copies/mL (r2 = 0.991). Sensitivity was 40 copies/mL at a 100% hit rate. Intraexperimental CVs were 27.4-50.8%, and interexperimental CVs were 29.3-81.5%. Although COBAS TaqMan showed an excellent titer correlation with AMPLICOR (r2 = 0.960), mean titer obtained with COBAS TaqMan was 3.1 times higher than that with AMPLICOR (p = 0.002), and 7.1 times higher in a sample of subtype C, suggesting discrepancies in HIV-1 RNA quantification between the two kits. This point should be noted when AMPLICOR is replaced by COBAS TaqMan.
AB - We evaluated the use of COBAS TaqMan HIV-1 for highly pure system (COBAS TaqMan) recently developed as a second-generation quantification of human immunodeficiency virus type 1 (HIV-1) RNA. The linearity, sensitivity, reproducibility, and effects of possibly interfering materials were examined and results compared to those of AMPLICOR HIV-1 MONITOR Test version 1.5 (AMPLICOR) using 6 virus isolates that were all different subtypes. Excellent linearity was obtained at 1.67 x 10(2)-1.73 x 10(6) copies/mL (r2 = 0.991). Sensitivity was 40 copies/mL at a 100% hit rate. Intraexperimental CVs were 27.4-50.8%, and interexperimental CVs were 29.3-81.5%. Although COBAS TaqMan showed an excellent titer correlation with AMPLICOR (r2 = 0.960), mean titer obtained with COBAS TaqMan was 3.1 times higher than that with AMPLICOR (p = 0.002), and 7.1 times higher in a sample of subtype C, suggesting discrepancies in HIV-1 RNA quantification between the two kits. This point should be noted when AMPLICOR is replaced by COBAS TaqMan.
UR - http://www.scopus.com/inward/record.url?scp=34247869710&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34247869710&partnerID=8YFLogxK
U2 - 10.11150/kansenshogakuzasshi1970.81.1
DO - 10.11150/kansenshogakuzasshi1970.81.1
M3 - Article
C2 - 17338309
AN - SCOPUS:34247869710
SN - 0387-5911
VL - 81
SP - 1
EP - 5
JO - Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases
JF - Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases
IS - 1
ER -
